Stay updated on COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib
Sign up to get notified when there's something new on the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page.

Latest updates to the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedThe page’s displayed interface revision/version is updated from v3.5.2 to v3.5.3, indicating a system release on ClinicalTrials.gov rather than a change to the trial’s record history.SummaryDifference0.0%

- Check28 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the study history.SummaryDifference0.0%

- Check56 days agoChange DetectedAdded revision v3.5.0 to the history and removed revision v3.4.3.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision metadata updated: v3.4.3 added and v3.4.2 removed.SummaryDifference0.0%

- Check92 days agoChange DetectedRevision: v3.4.2 was added to the history list. The notice about government funding operating status and the earlier revision v3.4.1 were removed.SummaryDifference0.3%

- Check99 days agoChange DetectedAdministrative updates were added to the history: a new notice about funding and a new version marker (v3.4.1) replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib
Enter your email address, and we'll notify you when there's something new on the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page.